IM Cannabis Corp.
Business
IM Cannabis Corp. is an international medical cannabis company that imports, distributes and sells premium cannabis products through retail pharmacies, online platforms and logistics hubs. It offers dried flowers, full-spectrum extracts and oils under IMC and other premium brands, and provides repackaging and EU‑GMP production services. Key segments are Israeli retail/distribution (IMC Holdings, Pharm Yarok), German operations via Adjupharm and logistics, and brand sourcing/licensing. The company serves patients in Israel and Germany through pharmacies, home delivery and online channels, leveraging international suppliers.
Summary from filing dated 2025-03-31
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-11.75M |
| Total assets | $31.74M |
| Total liabilities | $35.35M |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is IM Cannabis Corp.'s CIK number?
IM Cannabis Corp.'s SEC CIK number is 0001792030 (1792030). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find IM Cannabis Corp.'s SEC filings?
All of IM Cannabis Corp.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.